Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06565923 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study on the Staging and Prognosis Model of Bladder Cancer

Study acronym: 2024-SR-386
StatusUnknown
PhaseNot specified
Started2024-03-18
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 22, 2024 (before its estimated July 18, 2025 completion). Its status may not reflect the trial's current state.

Amendment history

2026-09-06
minor
Trial status changed: Active, Not Recruiting → Unknown
Firstly, we retrospectively gathered the patient information who compliant with the criteria from 2012 to 2023, encompassing basic information, clinical information, along with MRI images, blood/urine samples, and tissue samples, for conducting relevant analyses of radiomics. Subsequently, based on artificial intelligence technology, deep learning and machine learning models were established on the basis of MRI radiomics and pathological histomics. Ultimately, the following research aims were accomplished: 1. Primary research objective: To explore the role of artificial intelligence and multimodal omics features in the staging and prognosis monitoring of bladder cancer. 2. Secondary objective: To explore the correlations among radiomics, case histomics, and test omics.
Trial Details
NCT Number NCT06565923
Lead Sponsor The First Affiliated Hospital with Nanjing Medical University
Collaborators: Suzhou Municipal Hospital, Yixing People's Hospital, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Huai an First People Hospital, Jiangsu Province Hospital of Traditional Chinese Medicine, The First Affiliated Hospital of Zhengzhou University, The second affiliated hospital of Xuzhou medical university
Conditions Bladder Cancer
Enrollment 200 participants
Start Date 2024-03-18
Primary Completion 2025-07-18 (estimated)
Study Completion 2025-07-18 (estimated)
Updated on ClinicalTrials.gov 2024-08-22